company

Harbin Jixianglong Biotech Co., Ltd.

Industry: pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

Frequently asked questions

How many FDA warning letters has Harbin Jixianglong Biotech Co., Ltd. received?
Argus HQ has recorded 1 FDA warning letter for Harbin Jixianglong Biotech Co., Ltd..
What FDA recalls has Harbin Jixianglong Biotech Co., Ltd. issued?
Argus HQ has not recorded an FDA recall tied to Harbin Jixianglong Biotech Co., Ltd. in our current dataset.
Is Harbin Jixianglong Biotech Co., Ltd. FDA compliant?
Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Harbin Jixianglong Biotech Co., Ltd.. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.